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ABSTRACT
Objective: Crataeva nurvala (CN) is used for its therapeutic effects, but its effect on the thyroid gland in euthyroid conditions and mechanism behind 
its thyrotropic activity in hypothyroidism is still not explored. This study screened the pharmacological effect of the ethanolic extract of the bark of CN 
on thyroid hormones, free and total thyroxine (FT4 and T4), triiodothyronine (T3), thyroid-stimulating hormone (TSH) levels, and thyroid histology in 
normal Swiss albino female mice.
Methods: Eighteen animals of 28–33 g were segregated into three groups: Group I treated with vehicle (NOR+VEH), Group II administered CN 
400 mg/kg (NOR+CN 400), and Group III given CN 600 mg/kg (NOR+CN 600), for 15 days, per os (p.o.). The variation in the T4, FT4, T3, and TSH levels 
was recorded using ELISA, 24 h after the last dose, and T3/T4 ratio thus calculated along with the histopathological studies of the thyroid gland.
Results: The findings were presented as mean ± standard error of the mean, using one-way ANOVA, followed by Dunnett’s post-tests to compare all 
columns with the control. NOR+CN 600 has shown thyroid protective effect through retaining euthyroid profile, normal T3/T4 ratio, and near-normal 
histology. However, NOR+CN 400 had shown the significant decline in T3/T4 ratio and pathological changes in thyroid histology, in comparison with 
the control and NOR+VEH group.
Conclusion: The higher dose of CN was found to sustain the euthyroid levels through retention of iodothyronine deiodinases activity, facilitating the 
peripheral conversion of T4 to T3, and in retaining normal histoarchitecture of the thyroid gland in contrary to a lower dose.
Keywords: Varuna, Thyroxine, Triiodothyronine, Iodothyronine deiodinase, Euthyroid.
INTRODUCTION
Crataeva nurvala (CN) commonly known as Varuna is reported 
to possess various pharmacological activities such as analgesic, 
anthelmintic, antiarthritic, antibacterial, anticancer, antidiabetic, 
antidiarrheal, antifertility, anti-hemolytic, anti-snake venom, anti-
inflammatory, antimycotic, antioxidant, antiurolithiatic, cardioprotective, 
hepatoprotective, nephroprotective, neuroprotective, and antimalarial 
activities. It is also found to be effective in treating urinary tract infections 
as evident from various in vivo–in vitro studies in disease conditions [1-6].
Furthermore, Varuna is a part of various polyherbal Ayurvedic, 
Siddha, and commercially manufactured formulations, used for 
certain pharmacological actions such as Asmarihara kasaya (anti-
hypertriglyceridemia and hepatoprotective), Pashanabhedadi Ghrita 
(antinephrolithiatic and antioxidant), Vedikara silasathu parpam 
and Nerunjil kudineer (anti-inflammatory), Himplasia (Himalaya 
Herbal Healthcare, Bengaluru) used for Benign Prostatic Hyperplasia, 
and Neeri (Aimil Pharmaceuticals India Ltd., New Delhi) as 
nephroprotective [7-11].
In a recent study, the bark extract of CN (CN 600 mg/kg) had shown to 
possess significant thyroid stimulant activity when compared with the 
standard therapy i.e. levothyroxine in propylthiouracil (PTU) induced 
hypothyroidism. It showed significant reduction in cholesterol levels 
and improved thyroid hormone levels, proving its beneficial role in the 
treatment of hypothyroidism and associated hypercholesterolemia. 
However, the lower dose (CN 400 mg/kg), despite raising T4 levels, 
in an erratic manner, raised thyroid stimulating hormone (TSH) also, 
for which mechanism was not clear [12]. Moreover, its effect in the 
euthyroid state, when used for other ailments in the form of polyherbal 
preparations or certain extracts, is still unexplored. For estimating the 
mechanism, an additional diagnosis like T3 is also required, which was 
not estimated in previous studies, needed to be estimated.
Hence, this study was framed to evaluate the per se effect of CN on 
thyroid hormone levels, thyroid histology, and its mechanism through 
estimating thyroid hormones, i.e. T4 (total and free) and T3 levels, TSH, 




Swiss Albino healthy female mice, having age around 3–5 months and 
body weight 28–33 g, were purchased from “Panacea Biotec Ltd., Lalru 
(140501), India.” Animals were kept in cages made of polypropylene, 
under specified temperature conditions such as 25±2°C and relative 
humidity 30–70% with the maintenance of 12-h night and 12-h day 
cycle. Animals were nourished with standard pellets of food purchased 
from “Shree Jagdambey Feed Industries” situated in Moga (Punjab), 
and potable water was supplied on a free basis. The prior approval for 
the conduct of the study was taken from the Institutional Animal Ethics 
Committee (IAEC) under Protocol no.: IAEC-CTIPS/2015/VII/0042 
(PCL-M) as per the guidelines of the Committee for the Purpose 
of Control and Supervision on Experiments on Animals (CPCSEA), 
New Delhi.
Procurement of plant material: CN
The CN bark (3.5 kg) was purchased from Herbal Health Research 
Consortium Pvt., Ltd. (HHRC), Amritsar, from Lot No. VRN-024 along 
with Certificate of Analysis (COA) whose A. R. No. was 06/2015/
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i10.27245
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IH/086, in consistency with Q.S.I.M.P.; 10: 106-108. Certified purchase 
voucher with voucher no. HHRC/RT/0416/15–16, along with the bark 
sample, was deposited to the Department of Pharmacology, CT Institute 
of Pharmaceutical Sciences, for further reference.
Preparation of extract
The CN bark extract was prepared through triple maceration 
strategy [13]. 3.5 kg of CN bark was dried in shade and rendered free 
of dust. The size reduction was achieved, first by manual crushing, 
thereafter undergoing an electrical grinding (sieve size #16). Ethanol 
(1 kg in 3 L) was used as a solvent to macerate the coarse powder at 
room temperature with periodic shaking. The straining was done 
by layer muslin fabric in 2 folds, and the marc pressing was done to 
extricate the solvent. The individual filtrates were obtained, combined, 
and filtered through Whatman No. 1 paper. This procedure was 
rehearsed every 3rd day to achieve triple maceration. All the filtrates 
were stored in light-resistant bottles. The recovery of the solvent was 
done under vacuum at 37°C and allowed to concentrate to get dark 
semisolid mass. The yield obtained was 1.37%.
Chosen amount of extract, i.e. 400 mg/kg and 600 mg/kg was used, 
based on available literature, scientific evidence for its neurological, 
hepatic and renal safety, therapeutic efficacy, and thyrotropic activity 
in PTU-induced hypothyroidism to evaluate its mechanism [12]. For 
administration, suspension using Gum Acacia (1%) and preserved at 
2–8°C in light-resistant bottle [14-17].
Preliminary phytochemical screening
The qualitative phytochemical estimation of CN ethanolic extract was 
conducted using tests such as Keller-Killiani test, sodium hydroxide 
test, lead acetate test, Salkowski test, Lieberman’s test, silver nitrate 
test, and frothing test. Every reagent taken was of analytical grade.
Experimental procedure
Mice of 28–33 g were segregated into three groups, i.e. Group I, vehicle 
treated, and Groups II and III, administered with CN 400 mg/kg BW 
and CN 600 mg/kg BW for 15 days, orally. The variation in the T4, FT4, 
T3, and TSH was analyzed on the 15th day. Dosage administration was 
done every day between 9.00 am and 10.00 am to avoid any circadian 
alteration.
Serum preparation
The blood samples were ensured to be collected after 24 h of the 
last dose administered, through retro-orbital puncture method. The 
blood specimen was permitted to get coagulate, and centrifugation for 
20 min was carried out thereafter to obtain serum. The serum, thus, 
obtained was preserved at −2°C–−8°C until examined for biochemical 
examinations.
Biochemical parameter estimation in serum
Serum T4, FT4, T3, and TSH were estimated by ELISA as per the 
instructions given in protocol by ERBA Lachema s.r.o., Czech Republic, 
and Calbiotech Inc., Austin, CA, at end of the study.
Histological studies
The histology of thyroid gland was performed using hematoxylin and 
eosin staining method [18]. The thyroid glands were removed, rinsed, and 
immersed in formaldehyde solution. The section was first deparaffinized, 
and slide was flamed over the burner and repeatedly agitated in xylene for 
3–5 min. The section is first hydrated with water and then in decreasing 
concentration of alcohol, i.e. 100%, 90%, 80%, and 70% for 30–60 s, then 
washed under tap water, rinsed with distilled water, and drained properly 
before staining with hematoxylin and eosin solution. The cell nuclei will 
be viable in blue color, erythrocytes in red color, and muscle and other 
connective tissue with cytoplasm in shades of pink.
Statistical analysis
All the findings are presented as mean ± standard error of the mean 
(n=6), for serum biochemical parameter estimation, using one-way RM 




The CN was screened for phytochemical estimation using various 
qualitative tests and ensured the presence of various phytochemicals 
such as glycosides, saponins, alkaloids, flavonoids, and terpenoids.
Effect of CN on thyroid hormones
Thyroxine (T4 and FT4)
Administration of the CN to healthy mice for 15 days, significantly 
soared T4 (**p<0.01) and FT4 (*p<0.05) levels in NOR+CN 400, whereas 
no deviation from normal levels, on the significant basis, was observed 
in NOR+CN 600 when compared to normal control, i.e., NOR+VEH (Figs. 
1 and 2).
Triiodothyronine (T3)
Administration of extract in healthy mice for 15 days significantly 
reduced the T3 levels in both the groups, i.e. highly significant decline in 
NOR+CN 400 (***p<0.001) and significantly NOR+CN 600 (**p<0.01) as 
compared to NOR+VEH (Fig. 3).
T3/T4 ratio
The calculated T3/T4 ratio was found to be significantly less in NOR+CN 
400 (**p<0.01), with respect to the normal control, whereas this ratio 
has been found to near normalcy in case of NOR+CN 600 (Fig. 4).
Effect on TSH
Administration of CN for 15 days in normal healthy female mice had not 
significantly altered the TSH levels in any of the test group with respect 
to normal control, thus depicting the subclinical changes at T3 levels 
(Fig. 5).
Histology of thyroid gland
The transverse section (T.S.) of thyroid gland of the normal group 
(NOR+VEH) showed the appearance of normal structural features 
such as follicular cells embedded in cuboidal epithelium (f), colloidal 
appearance in follicles with slight variation in size (co), parafollicular 
cells or C-cells clustered in between the follicles (pf), and fenestrated 
capillaries (ca) with visible appearance of interlobular connective 
tissue (il) (Fig. 6a), whereas the thyroid gland in NOR+CN 600 
appeared to have reduced follicular size (fr) with undistinguished 
columnar epithelium (ue), the presence of C-cells (pf), few capillaries 
(ca), and large vacuole spaces (va) (Fig. 6b). The thyroid gland T.S. of 
group NOR+CN 600 depicted the bunch of follicles of variable size (fv) 
with cuboidal epithelium and abundant follicular and cluster of C-cells 
(pf) with the presence of colloid in different intensity (co) and blood 
capillaries (ca) (Fig. 6c).
DISCUSSION
Thyroxine (T4) is the principle prohormone secreted from the thyroid 
gland. T4 thus produced is metabolically converted into its biologically 
active form T3, through the process of outer-ring monodeiodination by 
thioredoxin fold-containing selenoenzymes, known as iodothyronine 
deiodinases in cytoplasm and nucleus of target/extrathyroidal 
tissues mainly liver, kidneys, etc. T3 is secreted in small amount by the 
thyroid gland (13%) and the majority is formed in peripheral tissues 
through Type I 5’idothyronine monodeiodinase (5’-DI) by peripheral 
monodeiodination to carry out pro-metabolic, pro-enzymatic, and 
lipolytic effects [19,20]. Suppression in levels of both T4 and T3 is 
seen in conditions of hypothyroidism or due to the effect of certain 
goitrogens like bamboo shoots as a food entity or bark of Ficus 
racemosa Linn. [21,22]. Any change in 5’DI, i.e., inhibition is reflected 
by a decrease in T3 concentration and T3/T4 ratio, despite the increase 
in T4 concentration [23].
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Fig. 1: Effect of Crataeva nurvala on total thyroxine levels (the 
values are presented as mean ± standard error of the mean (n=6), 
for serum biochemical parameter estimation, using one-way RM 
ANOVA followed by Dunnett’s post-test to compare all columns 
with the control group,**p<0.01)
Fig. 2: Effect of Crataeva nurvala on free thyroxine levels (the 
values are presented as mean ± standard error of the mean (n=6), 
for serum biochemical parameter estimation, using one-way RM 
ANOVA followed by Dunnett’s post-test to compare all columns 
with the control group,*p<0.05)
Fig. 3: Effect of Crataeva nurvala on triiodothyronine levels (the 
values are presented as mean ± standard error of the mean (n=6), 
for serum biochemical parameter estimation, using one-way RM 
ANOVA followed by Dunnett’s post-test to compare all columns 
with the control group,**p<0.01 and ***p<0.001)
Fig. 4: Effect of Crataeva nurvala on T3/T4 ratio (the values are 
presented as mean ± standard error of the mean (n=6), for serum 
biochemical parameter estimation, using one-way RM ANOVA 
followed by Dunnett’s post-test to compare all columns with the 
control group,**p<0.01)
Fig. 5: Effect of Crataeva nurvala on thyroid-stimulating hormone 
(the values are presented as mean ± standard error of the mean 
(n=6), for serum biochemical parameter estimation, using one-
way RM ANOVA followed by Dunnett’s post-test to compare all 
columns with the control group)
In this study, administration of the ethanolic extract of CN to healthy 
mice for 15 days significantly increased the levels of T4 (**p<0.01) 
and FT4 (*p<0.05) in NOR+CN 400, with a significant reduction in the 
T3 levels (***p<0.001) (Figs. 1-3). Whereas, in NOR+CN 600, i.e. at the 
higher dose, the insignificant change was observed in thyroxine levels 
with significant (**p<0.01) decrease is T3 levels as compared to normal 
control i.e. NOR+VEH (Figs. 1-3). However, no significant change was 
observed in TSH levels (Fig. 4). Hence, this extract might have some 
inhibitory effect on 5’DI, thus affecting the peripheral deiodination, but 
this 5’DI inhibition is more marked with the lower dose as compared 
to the higher dose as T3/T4 ratio in NOR+CN 400 has significantly 
(**p<0.01) decreased as compared with NOR+CN 600 that retained the 
levels compared to normal group.
These results are in line with the study by Panda and Kar, 1999, done 
on root extract of Withania somnifera, given at the dose 1.4 g/kg to 
female mice for about 20 days along with the additional parameter 
observed, i.e., hepatic glucose-6-phosphatase [24]. Tahiliani and Kar 
1999 reported similar findings in their study on Moringa oleifera leaf 
extract, which showed approximately 30% reduction in T3, despite 
marked increased in T4 levels with antiperoxidative effects and is 
suggested to be used in hyperthyroidism conditions [25]. Aegle 
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marmelos extract when studied by Kar et al. 2006, it was found that it 
could decrease T3 concentration by 62% depicting its possibility to be 
used in the regulation of thyroid disorder like hyperthyroidism [26]. 
Since our study also revealed that only T4 but not T3 was soared by 
lower dose, plant might stimulate the synthesis or the release of T4, 
directly at the glandular level but not through peripheral conversion of 
T4 to T3 which make it suitable for use in hyperthyroidism, while being 
higher dose remaining safe to be used for other ailments with respect 
to thyroid function.
Finding from previous studies using the ethanolic extract of CN in PTU-
induced hypothyroidism revealed that CN 600 mg/kg has thyrotropic 
action as it significantly raised T4 levels (***p<0.001) with a concomitant 
decrease in TSH (*p<0.05) and associated hypercholesterolemia 
(***p<0.001). However, the lower dose proved to be less effective in 
correcting the disorder and seen to increase TSH. This may be attributed 
to more marked inhibition of 5’DIs by CN 400 mg/kg, thus inhibiting the 
formation of T3 and rising the TSH.
Structurally, the thyroid gland in rodents is similar to that of humans, 
except the difference in size of the follicles that are comparatively small 
and are surrounded by the cuboidal epithelium [27,28]. Petrova et al. 
2014 demonstrated that the administration of l-thyroxine or availability 
of thyroid hormones is characterized by the presence of large size 
follicles, availability of more colloid, reduction in resorptive vacuoles 
with flattened follicular epithelium as it is evident from the images of 
normal (NOR+VEH), and the group administered with CN 600 mg/kg, 
where no or less vacuolization was present and follicular size was large 
with flattened cuboidal epithelium, colloidal appearance in follicles, 
slightly variable in size, parafollicular cells, or C-cells in between the 
follicles, fenestrated capillaries with visible appearance of interlobular 
connective tissue [29]. Ali Rajab et al. 2015 demonstrated that the 
supranormal levels of thyroid hormones or conditions resembling 
hyperthyroidism distort the morphology of the gland characterized by 
distention of lumen of follicles, reduction in thyrocyte height, follicular 
remodeling (fusion), and thyrocyte death due to lack of trophic effect 
and cytoprotection offered by TSH [30]. NOR+CN 400 (Fig. 6b) depicted 
the hypotrophic follicles i.e., reduced in size and undistinguished 
epithelium, with presence of C-cells, capillaries, and vacuoles as 
compared to NOR+VEH group (Fig. 6 a).
NOR+CN 600 (Fig. 6c) depict the bunch of follicles with fused epithelium 
and abundant follicular and a cluster of C-cells with the presence of 
colloid in different intensity. However, blood capillaries and C-cells are 
visible with a number of follicles.
The thyroid gland comprises of acini or follicles that are spherical 
bodies that selectively absorb iodine in the form of iodide ions, 
I– from the blood circulation for the production of the thyroid 
hormones, and also for its adequate storage in thyroglobulin (Tg). 
25% of the body’s I- ions are in the thyroid gland. Follicles contain 
a region called the follicular lumen, containing colloid comprising 
of a protein, Tg that serves as the reservoir of materials for the 
thyroid hormone production and, to a lesser extent, also acts as a 
reservoir for already synthesized thyroid hormones. The follicles 
are lined by multiple cuboidal cells, whose size varies depending on 
age and locality [31,32]. The size of the follicles and the follicular 
lumen is found to be reduced in NOR+CN 400 group, thus indicating 
the depletion of colloid accompanied by vacuole formation, whereas 
normal follicular size with no vacuolization was seen in NOR+CN 
600 (Fig. 6a and b). “C cells” or parafollicular cells which secrete 
calcitonin were found in abundance, scattered within the follicular 
cells and in the spaces between the spherical follicles in NOR+VEH 
and NOR+CN 600; however, they were poorly localized in NOR+CN 
400. As the acini size has decreased in NOR+CN 400, the acinar 
epithelium appears more cuboidal as compared to NOR+VEH and 
NOR+CN 600, in which with the increased size of follicles and the 
epithelial lining becomes flatter or low cuboidal.
As per the findings of this study, CN 400 mg/kg was found to be 
beneficial to be used in hyperthyroidism, as evident from raised 
T4 and reduced T3 and T3/T4 ratio, whereas CN 600 mg/kg was 
able to maintain euthyroid state in per se or hypothyroid mice, 
compared to the normal group. For future studies, CN extract must 
be studied extensively for its effect on peripheral organs also such 
as determination of a additional parameter for thyroid function 
and glucose-6-phosphatase (G-6-Pase) activity in liver tissues as 
carbohydrate metabolism is also influenced by thyroid hormones 
and moreover the anti-peroxidative effects in relation to thyroid 
disorders [33]. However, before human therapy, further investigations 
are required such as the direct measurement of 5’DI using specific 
radioimmunoassay for more confirmation.
CONCLUSION
The ethanolic extract of CN is thyrotropic, stimulatory at glandular 
level but possesses the 5’DIs inhibitory activity in a dose-specific 
manner. Lower dose, i.e. CN 400 mg/kg is suitable to be used in 
hyperthyroidism, whereas higher dose, i.e. CN 600 mg/kg is found to 
be effective in hypothyroidism, in maintaining euthyroid levels and in 
retaining normal histoarchitecture of the thyroid gland as evident from 
preclinical studies.
Fig. 6: Microscopic images of thyroid glands  demonstrating the histological changes after the administration of the vehicle, Crataeva 
nurvala (CN) 400 mg/kg and CN 600 mg/kg for 15 days (a) control, NOR+VEH (b) NOR+CN 400 (c) NOR+CN 600; where pf- parafollicular 
cells or C-cells, f-follicles, co - colloid, ca - capillaries, il - interlobular connective tissue, fr - reduced follicular size, ue - undistinguished 
columnar epithelium, va - vacuoles, and fv- variable size follicles. Hematoxylin and eosin  staining (×450)
a b c
302
Asian J Pharm Clin Res, Vol 11, Issue 10, 2018, 298-302
 Kaur and Verma 
ACKNOWLEDGMENTS
This project was a part of M. Pharmacy (Pharmacology) research 
protocol. The support and guidance of all teaching, non-teaching, and 
technical staff of the Department of Pharmacology, CT Institute of 
Pharmaceutical Sciences, School of Pharmaceutical Sciences, Lovely 
Professional University, for providing the basic facilities, resources, 
and in the completion of the study and communication of research 
outcomes is highly appreciable.
AUTHOR’S CONTRIBUTIONS
All the authors have significantly contributed to the concept, design, 
definition of intellectual content, literature research, the conduct of the 
study, manuscript editing, preparation, and review.
CONFLICTS OF INTEREST STATEMENT
The authors mentioned in this paper do not have any personal or 
financial relationship with any other person or organization that can 
influence the content of the paper.
REFERENCES
1. Bopana N, Saxena S. Crataeva nurvala: A valuable medicinal plant. 
J Herbs Spices Med Plants 2008;14 1 Supp 2:107-27.
2. Khattar V, Wal A. Utilities of Crataeva nurvala. Int J Pharm Pharm Sci 
2012;4:21-6.
3. Kamath R, Shetty D, Bhat P, Shabaraya AR, Hegde K. Evaluation of 
antibacterial and anthelmi tic activity of root extract of Crataeva nurvala. 
Pharmacologyonline 2011;1:671-2.
4. Chidambaram K, Albert J, Karpagam K. Antipyretic activity of 
Crateva magna bark on tab-vaccine induced pyrexia. Int J Pharm Sci 
Res 2011;2:856-9.
5. Shelkea TT, Bhaskar VH, Adkara PP, Jhaa U, Oswala RJ. 
Nephroprotective activity of ethanolic extract of stem barks of 
Crataeva nurvula Buch Hum. Int J Pharm Sci Res 2011;2:2712-7.
6. Pattanaik SO, Si SC, Nayak SS. Evaluation of free radical scavenging 
activity, wound healing activity and estimation of phenolic, flavonoid 
and proanthocyanidin contents of the plant “Crateva magna”. Asian J 
Pharm Clin Res 2012;5:168-71.
7. Bulbul L, Choudhuri MS. Effect of Asmarihara kasaya curna (ASM)-an 
ayurvedic formulation on lipid profile after chronic administration. Int J 
Basic Med Sci Pharm 2012;2:83-7.
8. Gupta SK, Baghel MS, Bhuyan C, Ravishankar B, Ashok BK, Patil PD. 
Evaluation of anti-urolithiatic activity of pashanabhedadi ghrita against 
experimentally induced renal calculi in rats. Ayu 2012;33:429-34.
9. Akila B, Manickavasakam K. Anti-inflammatory and ant nociceptive 
activity of two Siddha formulations in combination. Int J Pharm Sci Res 
2013;4:856-61.
10. Chakraborthy S, Karamakar D, Kolhapure SA. Evaluation of the 
efficacy and safety of Himplasia in BPH: A randomised, double-blind, 
placebo-controlled, phase III clinical trial. Med Update 2004;12:39-48.
11. Barwal A, Kumari S, Verma SK, Goyal PK, Sharma I, Sharma S, et al. 
Evaluation of herbal formulation neeri (NS-RF) for protective effect 
against heavy metal induced nephrotoxicity in rats. Indo Am J Pharm 
Sci 2015;5:2790-8.
12. Kaur A, Khurana N, Verma SK. Potential thyrotropic and 
antihypercholesteronemic activity exhibited by ethanolic extract of 
Crataeva nurvala bark. J Appl Pharm Sci 2017;7:69-73.
13. Hussain M, Bakhsh H, Aziz A, Majeed A, Khan IA, Mujeeb A, et al. 
Comparative in vitro study of antimicrobial activities of flower and 
whole plant of Jasminum officinale against some human pathogenic 
microbes. J Pharm Altern Med 2013;2:33-43.
14. Sikarwar MS, Patil MB. Antihyperlipidemic activity of Crataeva 
nurvula stem barks extracts. Indian J Pharm Educ Res 2012;46:378-82.
15. Bhattacharjee A, Shashidhara SC, Saha S. Neuroprotective activity of 
Crataeva nurvula Buch-Ham stem bark against scopolamine - Induced 
cognitive impairment via antioxidative activites in rats. Am J Ethnomed 
2014;1:371-83.
16. Panda A, Rath S, Pradhan D, Mahanty A, Gupta BK, Bala NN. 
Hepatoprotective activity of leaves of Crataeva magna (Lour.) DC. 
In different types of hepatotoxic rat models. Indo Am J Pharm Res 
2014;4:125-31.
17. Shelkea TT, Bhaskarb VH, Adkara PP, Jhaa U, Oswala RJ. 
Nephroprotective activity of ethanolic extract of stem barks of Crataeva 
nurvula Buch. Ham. Int J Pharm Sci Res 2011;2:2712-7.
18. Sayaki H, Azure B. Counterstain in the immunohistochemical evaluation 
of heavily pigmented nevomelanocytic lesion. Appl Immunohistochem 
1955;3:268-71.
19. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. 
Biochemistry, cellular and molecular biology, and physiological roles 
of the iodothyronine selenodeiodinases. Endocr Rev 2002;23:38-89.
20. Greenspan FS. The thyroid gland. In: Greenspan FS, Baxter JD, editors. 
Basic and Clinical Endocrinology. Englewood Cliffs, New Jersy: 
Prentice Hall International Inc.; 1994. p. 160-226.
21. Sarkar D, Chakraborty A, Bhattacharya C, Singh LH, Chandra AK. 
Exploration of goitrogenic/antithyroidal potentiality of bamboo-shoots 
in relation to thiourea. Int J Pharm Pharm Sci 2017;9:7-12.
22. Azharuddin M, Atif M, Ahmed MI, Bakhtiary SA, Ibrahim M. 
Evaluation of anti-thyroid activity of Ficus racemosa Linn bark in male 
rats. Int J Pharm Pharm Sci 2015;7:118-22.
23. Visser TJ, Vander dose-tobe I, Hennemann G. Conversion of 
thyroxine into triiodothyronine by rat liver homogenate. Biochem J 
1978;150:489-93.
24. Panda S, Kar A. Withania somnifera and Bauhinia purpurea in the 
regulation of circulating thyroid hormone concentrations in female 
mice. J Ethnopharmacol 1999;67:233-9.
25. Tahiliani P, Kar A. Role of Moringa oleifera leaf extract in the regulation 
of thyroid hormone status in adult male and female rats. Pharmacol Res 
2000;41:319-23.
26. Panda S, Kar A. Evaluation of the antithyroid, antioxidative and 
antihyperglycemic activity of scopoletin from Aegle marmelos leaves 
in hyperthyroid rats. Phytother Res 2006;20:1103-5.
27. Choksi NY, Jahnke GD, Hilaire CS, Shelby M. Role of thyroid 
hormones in human and laboratory animal reproduction health. Birth 
Defects Res (Part B) 2003;68:479-91.
28. U.S. EPA. Assessment of Thyroid Follicular Cell Tumors. Washington, 
DC: EPA 1998.
29. Petrova I, Mitevska E, Gerasimovska Z, Milenkova L, Kostovska N. 
Histological structure of the thyroid gland in apolipoprotein E deficient 
female mice after levothyroxine application. Contributions Sec Med 
Sci 2014;35:135-40.
30. Rajab NM, Ukropina M, Cakic-Milosevic, M. Histological and 
ultrastructural alterations of rat thyroid gland after short-term treatment 
with high doses of thyroid hormones. Saudi J Biol Sci 2017;24:1117-25.
31. Rice CO. Histologic structure of the normal thyroid gland: Variations 
and their significance in the interpretation of pathologic conditions of 
the thyroid gland. Arch Surg 1938;36:96-110.
32. Fawcett D, Jensh R. Bloom and Fawcett’s Concise Histology. 
New York: Arnold Publishers; 2002.
33. Muller MJ, Acheson KJ, Jequier E, Burger AG. Effects of thyroid 
hormones on oxidative and nonoxidative glucose metabolism in mice. 
Am J Physiol 1988;18:146-52.
